Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure-Reference-Cited by-同舟云学术

Lower Hospitalization and Healthcare Costs With Sacubitril/Valsartan Versus Angiotensin‐Converting Enzyme Inhibitor or Angiotensin‐Receptor Blocker in a Retrospective Analysis of Patients With Heart Failure

Published:2019-05-07 Issue:9 Volume:8 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Albert Nancy M.¹,Swindle Jason P.²,Buysman Erin K.³,Chang Chunlan⁴

Affiliation:

1. Cleveland Clinic Cleveland OH

2. Optum Chicago IL

3. Optum Eden Prairie MN

4. Novartis Pharmaceuticals Corporation East Hanover NJ

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

2. Forecasting the Impact of Heart Failure in the United States

3. Pharmacologic Therapy for Heart Failure With Reduced Ejection Fraction: Closing the Gap Between Clinical Guidelines and Practice

4. 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America;Yancy CW;Circulation,2016

5. FDA approves new drug to treat heart failure [press release]. Silver Spring MD: US Food and Drug Administration; 08 July 2015. Available at: https://wayback.archive-it.org/7993/20171102201703/https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm453845.htm. Accessed June 22 2018.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of sacubitril/valsartan on hospital readmissions in heart failure with reduced ejection fraction in Saudi Arabia: A multicenter retrospective cohort study;Medicine;2024-07-26

2. Comparative effectiveness of sacubitril/valsartan versus angiotensin receptor blockers in patients with heart failure with preserved ejection fraction: A real-world study;American Journal of Health-System Pharmacy;2024-03-01

3. Comparison of Outcomes Between Sacubitril/Valsartan and Enalapril in Patients With Heart Failure: A Systematic Review and Meta-Analysis;Cureus;2023-11-10

4. Effects of sacubitril-valsartan on heart failure patients with mid-range ejection fractions: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-10-24

5. Thirty-Day and 90-Day Episode of Care Spending Following Heart Failure Hospitalization Among Medicare Beneficiaries;Circulation: Cardiovascular Quality and Outcomes;2022-07